127 related articles for article (PubMed ID: 27074375)
1. Tailoring Fluorescent Dyes To Optimize a Hybrid RGD-Tracer.
Bunschoten A; van Willigen DM; Buckle T; van den Berg NS; Welling MM; Spa SJ; Wester HJ; van Leeuwen FW
Bioconjug Chem; 2016 May; 27(5):1253-8. PubMed ID: 27074375
[TBL] [Abstract][Full Text] [Related]
2. Tracers for Fluorescence-Guided Surgery: How Elongation of the Polymethine Chain in Cyanine Dyes Alters the Pharmacokinetics of a Dual-Modality c[RGDyK] Tracer.
Buckle T; van Willigen DM; Spa SJ; Hensbergen AW; van der Wal S; de Korne CM; Welling MM; van der Poel HG; Hardwick JCH; van Leeuwen FWB
J Nucl Med; 2018 Jun; 59(6):986-992. PubMed ID: 29449447
[TBL] [Abstract][Full Text] [Related]
3. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of two novel ⁶⁴Cu-labeled RGD peptide radiotracers for enhanced PET imaging of tumor integrin αvβ₃.
Hernandez R; Czerwinski A; Chakravarty R; Graves SA; Yang Y; England CG; Nickles RJ; Valenzuela F; Cai W
Eur J Nucl Med Mol Imaging; 2015 Nov; 42(12):1859-68. PubMed ID: 26016906
[TBL] [Abstract][Full Text] [Related]
5. Hybrid Imaging Labels: Providing the Link Between Mass Spectrometry-Based Molecular Pathology and Theranostics.
Buckle T; van der Wal S; van Malderen SJ; Müller L; Kuil J; van Unen V; Peters RJ; van Bemmel ME; McDonnell LA; Velders AH; Koning F; Vanhaeke F; van Leeuwen FW
Theranostics; 2017; 7(3):624-633. PubMed ID: 28255355
[TBL] [Abstract][Full Text] [Related]
6. Multimodal interventional molecular imaging of tumor margins and distant metastases by targeting αvβ3 integrin.
Bunschoten A; Buckle T; Visser NL; Kuil J; Yuan H; Josephson L; Vahrmeijer AL; van Leeuwen FW
Chembiochem; 2012 May; 13(7):1039-45. PubMed ID: 22505018
[TBL] [Abstract][Full Text] [Related]
7. Near-infrared fluorescent divalent RGD ligand for integrin αvβ₃-targeted optical imaging.
Ye Y; Akers W; Xu B; Bloch S; Odonkor C; Achilefu S
Bioorg Med Chem Lett; 2012 Sep; 22(17):5405-9. PubMed ID: 22871580
[TBL] [Abstract][Full Text] [Related]
8. Radiolabeled multimeric cyclic RGD peptides as integrin alphavbeta3 targeted radiotracers for tumor imaging.
Liu S
Mol Pharm; 2006; 3(5):472-87. PubMed ID: 17009846
[TBL] [Abstract][Full Text] [Related]
9. Dual-functional protein for one-step production of a soluble and targeted fluorescent dye.
Xiao Y; Zhang Q; Wang Y; Wang B; Sun F; Han Z; Feng Y; Yang H; Meng S; Wang Z
Theranostics; 2018; 8(11):3111-3125. PubMed ID: 29896306
[TBL] [Abstract][Full Text] [Related]
10. Integrin (αvβ3) Targeted RGD Peptide Based Probe for Cancer Optical Imaging.
Liu Z; Yu L; Wang X; Zhang X; Liu M; Zeng W
Curr Protein Pept Sci; 2016; 17(6):570-81. PubMed ID: 26721402
[TBL] [Abstract][Full Text] [Related]
11. Optimizing the Biodistribution of Radiofluorinated Barbiturate Tracers for Matrix Metalloproteinase Imaging by Introduction of Fluorescent Dyes as Pharmacokinetic Modulators.
Schwegmann K; Hohn M; Hermann S; Schäfers M; Riemann B; Haufe G; Wagner S; Breyholz HJ
Bioconjug Chem; 2020 Apr; 31(4):1117-1132. PubMed ID: 32181649
[TBL] [Abstract][Full Text] [Related]
12. Click Chemistry in the Design and Production of Hybrid Tracers.
Hensbergen AW; van Willigen DM; Welling MM; van der Wijk FA; de Korne CM; van Oosterom MN; Schottelius M; Wester HJ; Buckle T; van Leeuwen FWB
ACS Omega; 2019 Jul; 4(7):12438-12448. PubMed ID: 31460363
[TBL] [Abstract][Full Text] [Related]
13. Tumor uptake of the RGD dimeric probe (99m)Tc-G3-2P4-RGD2 is correlated with integrin αvβ3 expressed on both tumor cells and neovasculature.
Liu Z; Jia B; Shi J; Jin X; Zhao H; Li F; Liu S; Wang F
Bioconjug Chem; 2010 Mar; 21(3):548-55. PubMed ID: 20184307
[TBL] [Abstract][Full Text] [Related]
14. Rational design of fluorescent light-up probes based on an AIE luminogen for targeted intracellular thiol imaging.
Yuan Y; Kwok RT; Feng G; Liang J; Geng J; Tang BZ; Liu B
Chem Commun (Camb); 2014 Jan; 50(3):295-7. PubMed ID: 24244944
[TBL] [Abstract][Full Text] [Related]
15. Imaging integrin αvβ3 on blood vessels with 111In-RGD2 in head and neck tumor xenografts.
Terry SY; Abiraj K; Frielink C; van Dijk LK; Bussink J; Oyen WJ; Boerman OC
J Nucl Med; 2014 Feb; 55(2):281-6. PubMed ID: 24408894
[TBL] [Abstract][Full Text] [Related]
16. Fast clearing RGD-based near-infrared fluorescent probes for in vivo tumor diagnosis.
Cao J; Wan S; Tian J; Li S; Deng D; Qian Z; Gu Y
Contrast Media Mol Imaging; 2012; 7(4):390-402. PubMed ID: 22649045
[TBL] [Abstract][Full Text] [Related]
17. Near-infrared fluorescent RGD peptides for optical imaging of integrin alphavbeta3 expression in living mice.
Cheng Z; Wu Y; Xiong Z; Gambhir SS; Chen X
Bioconjug Chem; 2005; 16(6):1433-41. PubMed ID: 16287239
[TBL] [Abstract][Full Text] [Related]
18. New approach to quantification of molecularly targeted radiotracer uptake from hybrid cardiac SPECT/CT: methodology and validation.
Li S; Sinusas AJ; Dobrucki LW; Liu YH
J Nucl Med; 2013 Dec; 54(12):2175-81. PubMed ID: 24221992
[TBL] [Abstract][Full Text] [Related]
19. Preparation and characterization of 99mTc(CO)3-BPy-RGD complex as alphav beta3 integrin receptor-targeted imaging agent.
Zhang X; Chen X
Appl Radiat Isot; 2007 Jan; 65(1):70-8. PubMed ID: 17011200
[TBL] [Abstract][Full Text] [Related]
20. RGD-based PET tracers for imaging receptor integrin αv β3 expression.
Cai H; Conti PS
J Labelled Comp Radiopharm; 2013 May; 56(5):264-79. PubMed ID: 24285371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
